Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Tolterodine
Drug ID BADD_D02244
Description Tolterodine is an antimuscarinic drug that is used to treat urinary incontinence. Tolterodine acts on M2 and M3 subtypes of muscarinic receptors.
Indications and Usage For the treatment of overactive bladder (with symptoms of urinary frequency, urgency, or urge incontinence).
Marketing Status Prescription; Discontinued
ATC Code G04BD07
DrugBank ID DB01036
KEGG ID D00646
MeSH ID D000068737
PubChem ID 443879
TTD Drug ID D0BZ7W
NDC Product Code 65427-022; 0904-6593; 60687-330; 13668-190; 13668-189; 0904-6592; 60687-319
Synonyms Tolterodine Tartrate | Tartrate, Tolterodine | Tolterodine | Detrol | Detrol LA | Urotrol | PHA-686464B | PHA 686464B | PHA686464B | Detrusitol | Unidet
Chemical Information
Molecular Formula C22H31NO
CAS Registry Number 124937-51-5
SMILES CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Myalgia15.05.02.0010.001028%
Nausea07.01.07.0010.004110%
Neoplasm malignant16.16.01.0010.000402%Not Available
Nocturia20.02.03.0010.002569%Not Available
Oedema14.05.06.010; 08.01.07.006--Not Available
Oedema peripheral14.05.06.011; 08.01.07.007; 02.05.04.007--
Pain08.01.08.0040.002055%
Pain in extremity15.03.04.0100.001028%
Palpitations02.01.02.003--
Paraesthesia17.02.06.0050.001028%
Pollakiuria20.02.02.0070.003597%
Porphyria non-acute23.03.01.012; 09.01.10.003; 14.14.01.004; 03.08.01.0040.001541%Not Available
Pruritus23.03.12.0010.004110%
Pyrexia08.05.02.0030.002055%
Rash23.03.13.0010.002055%Not Available
Rash erythematous23.03.06.0030.001028%Not Available
Rotator cuff syndrome15.01.08.002; 12.04.03.0020.001541%
Scab23.03.03.0040.001028%Not Available
Scar23.03.11.008; 12.01.06.0080.001028%Not Available
Sinusitis22.07.03.007; 11.01.13.005--
Somnolence17.02.04.006; 19.02.05.003--
Swelling08.01.03.0150.001028%Not Available
Tachycardia02.03.02.0070.003083%Not Available
Upper respiratory tract infection11.01.13.009; 22.07.03.011--
Urinary incontinence20.02.02.010; 17.05.01.0080.001541%
Urinary retention20.02.02.0110.003597%
Urinary tract infection20.08.02.001; 11.01.14.0040.002569%
Urticaria23.04.02.001; 10.01.06.0010.002055%
Vertigo17.02.12.002; 04.04.01.0030.001028%
Vision blurred17.17.01.010; 06.02.06.0070.003597%
The 3th Page    First    Pre   3 4    Next   Last    Total 4 Pages